A multidisciplinary group that includes the University of Illinois at Urbana-Champaign and the University of Washington at Tacoma has developed a novel platform to diagnose infectious disease at the point-of-care, using a smartphone as the detection instrument in conjunction with a test kit in the format of a credit card.
The group is led by Illinois Electrical and Computer Engineering Professor Brian T. Cunningham; Illinois Bioengineering Professor Rashid Bashir; and, University of Washington at Tacoma Professor David L. Hirschberg, who is affiliated with Sciences and Mathematics, division of the School of Interdisciplinary Arts and Sciences.
Findings have been published in Analytical Chemistry, demonstrating detection of four horse respiratory diseases, and in Biomedical Microdevices, where the system was used to detect and quantify the presence of Zika, Dengue, and Chikungunya virus in a droplet of whole blood. Project collaborators include Dr. David Nash, a private practice equine expert and veterinarian in Kentucky, and Dr. Ian Brooks, a computer scientist at the National Center for Supercomputing Applications.
The low-cost, portable, smartphone-integrated system provides a promising solution to address the challenges of infectious disease diagnostics, especially in resource-limited settings or in situations where a result is needed immediately. The diagnostic tool’s integration with mobile communications technology allows personalized patient care and facilitates information management for both healthcare providers and epidemiological surveillance efforts. Importantly, the system achieves detection limits comparable to those obtained by laboratory-based methods and instruments, in about 30 minutes.
A useful capability for human point-of-care (POC) diagnosis or for a mobile veterinary laboratory, is to simultaneously test for the presence of more than one pathogen with a single test protocol, which lowers cost, saves time and effort, and allows for a panel of pathogens, which may cause similar symptoms, to be identified.
Infectious diseases remain the world’s top contributors to human death and disability, and with recent outbreaks of Zika virus infections, there is a keen need for simple, sensitive, and easily translatable point-of-care tests. Zika virus appeared in the international spotlight in late 2015 as evidence emerged of a possible link between an epidemic affecting Brazil and increased rates of microcephaly in newborns. Zika has become a widespread global problem—the World Health Organization (WHO) documented last year that since June 2016, 60 nations and territories report ongoing mosquito-borne transmission. Additionally, since Zika virus infection shares symptoms with other diseases such as Dengue and Chikungunya, quick, accurate diagnosis is required to differentiate these infections and to determine the need for aggressive treatment or quarantine.
For the research effort, horses were used as an animal model for respiratory disease in man and food animals. Says Dr. David Nash “You can often more easily develop diagnostic tools for human use by coming in to development from the animal side of things first. Many diseases show up first in animals, kind of the canary in the coal mine.”
A key project contributor, Dr. Nash comments on the financial impact of infectious disease outbreaks in horses: “It’s costly to horse owners and trainers, and disrupts the business operations of all equine sports. Consider this—on December 25, 2016 a single horse stabled at the Fair Grounds Race Course in New Orleans experienced a fever and subsequently developed neurological symptoms. The state diagnostic lab was 100 miles away and was closed for the Christmas holiday. The end result was an equine herpesvirus-1 (EHV-1) outbreak that resulted in the quarantine of over 200 horses at the racetrack and a serious financial loss for horse owners and the racetrack owner, Churchill Downs, Inc. Imagine the consequences if they ever had to postpone the Kentucky Derby due to a disease outbreak.”
The technology is intended to enable clinicians to rapidly diagnose disease in their office or in the field, resulting in earlier, more informed patient management decisions, while markedly improving the control of disease outbreaks. An important prerequisite for the widespread adoption of point-of-care tests at the patient’s side is the availability of detection instruments that are inexpensive, portable, and able to share data wirelessly over the Internet.
The system uses a commercial smartphone to acquire and interpret real-time images of an enzymatic amplification reaction that takes place in a silicon microfluidic chip that generates green fluorescence and displays a visual read-out of the test. The system is composed of an unmodified smartphone and a portable 3D–printed cradle that supports the optical and electrical components, and interfaces with the rear-facing camera of the smartphone.
The software application operating on the smartphone gathers information about the tests conducted on the microfluidic card, patient-specific information, and the results from the assays, that are then communicated to a cloud storage database.
Dr. Nash observes that, “This project is a game changer. This is the future of medicine—empowered front-line healthcare professionals. We can’t stop viruses and bacteria, but we can diagnose more quickly. We were able to demonstrate the clear benefit to humankind, as well as to animals, during the proposal phase of the project, and our results have proved our premise. Next, I want to go into the field, multiple sites, multiple geographic locations, and test in real-world situations.”
U of I graduate student and research assistant Fu Sun sees this project as fulfillment of one of her primary career objectives: “I entered graduate school with the hope to make a better world by developing biomedical devices that can facilitate effective disease prevention, diagnosis, or treatment. This project is in line with my goal since it provides a point-of-care solution for the fast diagnosis of infectious diseases. Connected to a cloud database through a smartphone, it helps healthcare providers in the field embrace the era of big data and the Internet of Things.”
The system represents the only platform to date that can multiplex detection of viral and other nucleic acid targets on a portable point-of-care setup using one droplet of bodily fluid, including whole blood.
The Latest on: Detecting pathogens
- 9 warning signs help you detect diseases through your faceon June 25, 2020 at 7:24 am
Any abnormalities on the face from acne to the color of the skin are pathological signs that need to be considered.
- US Failed To Detect Over 8.7 Million Coronavirus Cases In Marchon June 24, 2020 at 9:02 pm
Researchers said that the novel coronavirus infected more than 8.7 million people across the U.S. in March, a figure 80 times higher than what the government recorded at that time.
- Biocare Medical MACH4 Universal Polymer Utilized by CDC for Immunohistochemical Detection of SARS-CoV-2 in COVID-19 Caused Respiratory Infectionson June 24, 2020 at 5:17 pm
Biocare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) reagents, instrumentation and detection systems has been mentioned in a recent early release study by the Center ...
- New eDNA technique may reduce pathogens in aquatic animal tradeon June 24, 2020 at 8:58 am
A Washington State University researcher has developed new ways to detect the genetic signatures of disease in the international aquatic animal trade.
- Researchers develop eDNA method to prevent emergence of pathogenson June 24, 2020 at 8:09 am
As the SARS-CoV-2 puts a new focus on zoonotic pathogens, a Washington State University researcher has developed a method to use environmental DNA (eDNA) to detect disease in the vast international ...
- Pooled samples and eDNA-based detection can facilitate the “clean trade” of aquatic animalson June 24, 2020 at 2:18 am
The regional and international trade of live animals facilitates the movement, spillover, and emergence of zoonotic and epizootic pathogens around the world. Detecting pathogens in trade is critical ...
- Environmental DNA detection could cut pathogens in pet tradeon June 24, 2020 at 2:01 am
As the SARS-CoV-2 puts new focus on zoonotic pathogens, a Washington State University researcher has developed a method to use environmental DNA (eDNA) to detect disease in the vast international ...
- CNVs cause autosomal recessive genetic diseases with or without involvement of SNV/indelson June 23, 2020 at 3:50 pm
The contribution of CNVs to autosomal recessive (AR) conditions may be better recognized using a large clinical cohort. We retrospectively investigated the CNVs’ contribution to AR conditions in cases ...
- New imaging method could help detect and monitor liver diseaseon June 23, 2020 at 5:30 am
It's currently difficult to screen for certain liver diseases and to monitor these conditions once they're discovered. A team led by investigators at Massachusetts General Hospital (MGH) and the ...
- How IoT Sensors Can Help Detect and Control Contagious Diseaseson June 21, 2020 at 12:06 am
TAGS Health Care Internet of Things Sensors Jun 21, 2020The ongoing transmission of severe contagious diseases, such as COVID-19, and the delay in the identification of emerging threats, has led to ...
via Google News and Bing News